Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection.
Saved in:
| Title: | Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection. |
|---|---|
| Authors: | Hou MM; The Jenner Institute, University of Oxford, Oxford, UK.; Department of Biochemistry, University of Oxford, Oxford, UK., Harding AC; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, UK., Barber NM; Department of Biochemistry, University of Oxford, Oxford, UK., Kundu P; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK., Bach FA; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, UK., Salkeld J; The Jenner Institute, University of Oxford, Oxford, UK.; Department of Biochemistry, University of Oxford, Oxford, UK., Themistocleous Y; The Jenner Institute, University of Oxford, Oxford, UK., Greenwood NM; The Jenner Institute, University of Oxford, Oxford, UK., Cho JS; The Jenner Institute, University of Oxford, Oxford, UK.; Department of Biochemistry, University of Oxford, Oxford, UK., Barrett JR; The Jenner Institute, University of Oxford, Oxford, UK.; Department of Biochemistry, University of Oxford, Oxford, UK., Nugent FL; The Jenner Institute, University of Oxford, Oxford, UK.; Department of Biochemistry, University of Oxford, Oxford, UK., Rawlinson TA; The Jenner Institute, University of Oxford, Oxford, UK., Hodgson SH; The Jenner Institute, University of Oxford, Oxford, UK., Khozoee B; The Jenner Institute, University of Oxford, Oxford, UK., Mac Lochlainn DJ; The Jenner Institute, University of Oxford, Oxford, UK., Cowan RE; The Jenner Institute, University of Oxford, Oxford, UK.; Department of Biochemistry, University of Oxford, Oxford, UK., Poulton ID; The Jenner Institute, University of Oxford, Oxford, UK., Baker M; The Jenner Institute, University of Oxford, Oxford, UK., Kingham L; The Jenner Institute, University of Oxford, Oxford, UK., Mitton CH; The Jenner Institute, University of Oxford, Oxford, UK., Platt A; The Jenner Institute, University of Oxford, Oxford, UK., Lopez Ramon R; The Jenner Institute, University of Oxford, Oxford, UK., Ramos Lopez F; The Jenner Institute, University of Oxford, Oxford, UK., Thomas M; The Jenner Institute, University of Oxford, Oxford, UK., Skinner K; The Jenner Institute, University of Oxford, Oxford, UK.; Department of Biochemistry, University of Oxford, Oxford, UK., Quinkert D; The Jenner Institute, University of Oxford, Oxford, UK.; Department of Biochemistry, University of Oxford, Oxford, UK., Pipini D; The Jenner Institute, University of Oxford, Oxford, UK.; Department of Biochemistry, University of Oxford, Oxford, UK., Lias AM; The Jenner Institute, University of Oxford, Oxford, UK.; Department of Biochemistry, University of Oxford, Oxford, UK., Bardelli M; The Jenner Institute, University of Oxford, Oxford, UK.; Department of Biochemistry, University of Oxford, Oxford, UK., Edwards NJ; The Jenner Institute, University of Oxford, Oxford, UK., Donnellan FR; The Jenner Institute, University of Oxford, Oxford, UK.; Department of Biochemistry, University of Oxford, Oxford, UK., Biswas S; The Jenner Institute, University of Oxford, Oxford, UK., Rayner JC; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK., Nielsen CM; The Jenner Institute, University of Oxford, Oxford, UK.; Department of Biochemistry, University of Oxford, Oxford, UK., Silk SE; The Jenner Institute, University of Oxford, Oxford, UK.; Department of Biochemistry, University of Oxford, Oxford, UK., Draper SJ; The Jenner Institute, University of Oxford, Oxford, UK.; Department of Biochemistry, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Nahrendorf W; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, UK., Spence PJ; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, UK. pspence@ed.ac.uk., Minassian AM; The Jenner Institute, University of Oxford, Oxford, UK. angela.minassian@paediatrics.ox.ac.uk.; Department of Biochemistry, University of Oxford, Oxford, UK. angela.minassian@paediatrics.ox.ac.uk.; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK. angela.minassian@paediatrics.ox.ac.uk. |
| Source: | Nature communications [Nat Commun] 2025 Sep 25; Vol. 16 (1), pp. 8385. Date of Electronic Publication: 2025 Sep 25. |
| Publication Type: | Clinical Trial, Phase I; Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
